The Pandemic Institute (TPI), founded in 2021 and based in Liverpool, England, is a collaboration of academic, healthcare, civic and industrial partners dedicated to predicting, preparing for and responding to emerging infections and pandemic threats.
The Institute was founded in 2021 with a mission to tackle emerging infections and ensure that the world will never again be as unprepared for a pandemic as it was in December 2019. Its establishment built upon LiverpoolâÂÂs existing strengths in infectious-disease research, including the work of the NIHR Health Protection Research Unit in Emerging and Zoonotic Infections (since 2014) which was active in the UK response to Ebola, Zika and COVID-19. The Institute launched with an initial philanthropic donation of ã10 million awarded to the region in recognition of LiverpoolâÂÂs life-saving research and innovation during the COVID-19 pandemic. Its first director was Matthew Baylis. In 2022 he was succeeded by professor of neurology Tom Solomon.
TPI's mission is providing a comprehensive response across the pandemic lifecycle: from predicting pathogen emergence, through preparation and response, to recovery.
Its three core pillars are:
In addition, TPI emphasises collaboration with industry, academia, healthcare and civic partners as an essential component of its strategy.
The Institute is a partnership of multiple academic, healthcare and civic organisations based in the Liverpool city region. Key founding partners include:
The leadership of TPI is headed by Professor Tom Solomon CBE FRCP FMedSci (Professor of Neurology) who serves as Director of the Institute.